- Home
- CDLX vs NVCT Comparison
CDLX vs NVCT Comparison
Compare CDLX & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLX
- NVCT
- Stock Information
- Founded
- CDLX 2008
- NVCT 2020
- Country
- CDLX United States
- NVCT United States
- Employees
- CDLX N/A
- NVCT N/A
- Industry
- CDLX Computer Software: Programming Data Processing
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- CDLX Technology
- NVCT Health Care
- Exchange
- CDLX Nasdaq
- NVCT Nasdaq
- Market Cap
- CDLX 150.1M
- NVCT 167.0M
- IPO Year
- CDLX 2018
- NVCT 2022
- Fundamental
- Price
- CDLX $2.58
- NVCT $6.05
- Analyst Decision
- CDLX Hold
- NVCT Strong Buy
- Analyst Count
- CDLX 3
- NVCT 3
- Target Price
- CDLX $2.25
- NVCT $15.33
- AVG Volume (30 Days)
- CDLX 13.2M
- NVCT 81.4K
- Earning Date
- CDLX 11-05-2025
- NVCT 11-04-2025
- Dividend Yield
- CDLX N/A
- NVCT N/A
- EPS Growth
- CDLX N/A
- NVCT N/A
- EPS
- CDLX N/A
- NVCT N/A
- Revenue
- CDLX $266,201,000.00
- NVCT N/A
- Revenue This Year
- CDLX N/A
- NVCT N/A
- Revenue Next Year
- CDLX N/A
- NVCT N/A
- P/E Ratio
- CDLX N/A
- NVCT N/A
- Revenue Growth
- CDLX N/A
- NVCT N/A
- 52 Week Low
- CDLX $0.85
- NVCT $4.44
- 52 Week High
- CDLX $5.25
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- CDLX 61.95
- NVCT 44.20
- Support Level
- CDLX $2.21
- NVCT $5.94
- Resistance Level
- CDLX $2.97
- NVCT $6.17
- Average True Range (ATR)
- CDLX 0.48
- NVCT 0.29
- MACD
- CDLX 0.02
- NVCT 0.02
- Stochastic Oscillator
- CDLX 63.35
- NVCT 46.60
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.